EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 66 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $924,363 | +2.8% | 115,690 | +11.9% | 0.00% | – |
| Q2 2023 | $899,416 | +325.7% | 103,381 | +43.9% | 0.00% | – |
| Q1 2023 | $211,268 | -24.6% | 71,860 | -10.2% | 0.00% | – |
| Q4 2022 | $280,169 | -54.2% | 80,048 | +3.5% | 0.00% | – |
| Q3 2022 | $612,000 | +11.3% | 77,317 | +10.6% | 0.00% | – |
| Q2 2022 | $550,000 | -43.1% | 69,929 | -11.9% | 0.00% | – |
| Q1 2022 | $966,000 | +4.7% | 79,407 | +5.3% | 0.00% | – |
| Q4 2021 | $923,000 | +23.6% | 75,422 | +5.1% | 0.00% | – |
| Q3 2021 | $747,000 | +40.9% | 71,734 | +21.7% | 0.00% | – |
| Q2 2021 | $530,000 | – | 58,951 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,490,921 | $27,892,459 | 24.59% |
| ACUTA CAPITAL PARTNERS, LLC | 300,128 | $2,398,023 | 1.61% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,492,147 | $27,902,255 | 1.51% |
| Cormorant Asset Management, LP | 3,200,000 | $25,568,000 | 1.49% |
| Samsara BioCapital, LLC | 432,000 | $3,451,680 | 1.06% |
| Ghost Tree Capital, LLC | 325,000 | $2,596,750 | 0.85% |
| RA Capital Management | 3,370,506 | $26,930,343 | 0.53% |
| Ikarian Capital, LLC | 4,487 | $3,585,113 | 0.43% |
| Affinity Asset Advisors, LLC | 155,000 | $1,238,450 | 0.35% |
| SECTORAL ASSET MANAGEMENT INC | 176,080 | $1,406,879 | 0.27% |